Research progress in application characteristics of plant-derived exosome-like nanovesicles in intestinal diseases.
10.19540/j.cnki.cjcmm.20250425.201
- Author:
Yuan ZUO
1
;
Jin-Ying ZHANG
1
;
Sheng-Dong XU
1
;
Shuo TIAN
1
;
Ming-San MIAO
1
Author Information
1. Collaborative Innovation Center of Yuyao Whole Industry Chain, Henan University of Chinese Medicine Zhengzhou 450046, China.
- Publication Type:English Abstract
- Keywords:
extraction and purification;
inflammatory bowel disease;
intestinal diseases;
nanocarriers;
plant exosomes;
plant-derived exosome-like nanovesicles
- MeSH:
Humans;
Exosomes/metabolism*;
Animals;
Intestinal Diseases/metabolism*;
Plants/metabolism*;
Drug Carriers/chemistry*;
Drugs, Chinese Herbal/chemistry*;
Drug Delivery Systems;
Nanoparticles/chemistry*
- From:
China Journal of Chinese Materia Medica
2025;50(14):3868-3877
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease is a chronic, idiopathic, and recurrent gastrointestinal disorder with an unclear etiology and uncertain pathogenesis. Traditional treatment strategies rely on frequent administration of high doses of medication to reduce inflammation, whereas these approaches have limitations and may induce potential complications. Therefore, finding more effective and safe therapeutic drugs and methods is particularly important. Plant-derived exosome-like nanovesicles(PDELNs) are nano-sized vesicles with a lipid bilayer structure that are secreted by plant cells. The bioactive molecules contained within, such as lipids, proteins, and nucleic acids, can serve as information carriers, playing a role in the transmission of information and substances between cells and across species. PDELNs can carry and transfer their own bioactive substances or act as carriers for delivering other active components or drugs. Due to the high biocompatibility, low toxicity, and significant bioactivity, PDELNs have garnered widespread attention. Compared with other exosomes, PDELNs are not destroyed in the gastrointestinal tract when taken orally and can reach the intestines. This unique property makes PDELNs a promising oral nanodrug for treating intestinal diseases, showing great potential in this area. This article reviews recent research literature on PDELNs regarding the physicochemical characteristics, extraction and purification methods, functions, application characteristics and mechanisms in the treatment of intestinal diseases, and use as a carrier for treating intestinal diseases, aiming to provide a reference for the use of PDELNs in the treatment of intestinal diseases.
